207 related articles for article (PubMed ID: 21509762)
21. [Malignant peritoneal mesothelioma].
Wambach G; Weller P; Pietsch M; Kaufmann W
Dtsch Med Wochenschr; 1986 Mar; 111(13):517-8. PubMed ID: 3956396
[No Abstract] [Full Text] [Related]
22. [Clinicopathological study on 100 Japanese patients with peritoneal mesothelioma in Japan].
Naka H; Naka A
Gan No Rinsho; 1984 Jan; 30(1):1-10. PubMed ID: 6230471
[TBL] [Abstract][Full Text] [Related]
23. Sex difference in diffuse malignant peritoneal mesothelioma.
Yan TD; Popa E; Brun EA; Cerruto CA; Sugarbaker PH
Br J Surg; 2006 Dec; 93(12):1536-42. PubMed ID: 17048277
[TBL] [Abstract][Full Text] [Related]
24. Results of systemic pemetrexed-based combination chemotherapy versus cytoreductive surgery and hyperthermic intraperitoneal cisplatin and doxorubicin on survival in malignant peritoneal mesothelioma.
Saxena A; Chua TC
Lung Cancer; 2009 Nov; 66(2):269-70. PubMed ID: 19733416
[No Abstract] [Full Text] [Related]
25. Comprehensive management of diffuse malignant peritoneal mesothelioma.
Sugarbaker PH; Yan TD; Stuart OA; Yoo D
Eur J Surg Oncol; 2006 Aug; 32(6):686-91. PubMed ID: 16621431
[TBL] [Abstract][Full Text] [Related]
26. [Prolonged survival in peritoneal mesotheliomas. Apropos of a case].
Berthet B; Guieu C; Blanc AP; Palayodan A; Chamlian A; Assadourian R
Ann Chir; 1995; 49(1):76-7. PubMed ID: 7741473
[TBL] [Abstract][Full Text] [Related]
27. Malignant peritoneal mesothelioma.
Bani-Hani KE; Gharaibeh KA
J Surg Oncol; 2005 Jul; 91(1):17-25. PubMed ID: 15999348
[TBL] [Abstract][Full Text] [Related]
28. Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma--a prospective study of 70 consecutive cases.
Yan TD; Edwards G; Alderman R; Marquardt CE; Sugarbaker PH
Ann Surg Oncol; 2007 Feb; 14(2):515-25. PubMed ID: 17031722
[TBL] [Abstract][Full Text] [Related]
29. Peritoneal mesothelioma proposal for a staging system.
Sebbag G; Sugarbaker PH
Eur J Surg Oncol; 2001 Apr; 27(3):223-4. PubMed ID: 11373096
[No Abstract] [Full Text] [Related]
30. Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma.
Hesdorffer ME; Chabot JA; Keohan ML; Fountain K; Talbot S; Gabay M; Valentin C; Lee SM; Taub RN
Am J Clin Oncol; 2008 Feb; 31(1):49-54. PubMed ID: 18376228
[TBL] [Abstract][Full Text] [Related]
31. [Peritoneal tumor pathology - case no. 3 : peritoneal well-differentiated papillary mesothelioma].
Dartigues P
Ann Pathol; 2015 Aug; 35(4):327-37. PubMed ID: 26210689
[No Abstract] [Full Text] [Related]
32. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
Chua TC; Yan TD; Morris DL
J Surg Oncol; 2009 Feb; 99(2):109-13. PubMed ID: 19016259
[TBL] [Abstract][Full Text] [Related]
33. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma.
Ma GY; Bartlett DL; Reed E; Figg WD; Lush RM; Lee KB; Libutti SK; Alexander HR
Cancer J Sci Am; 1997; 3(3):174-9. PubMed ID: 9161783
[TBL] [Abstract][Full Text] [Related]
34. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
[TBL] [Abstract][Full Text] [Related]
35. Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study.
Gilly FN; Beaujard A; Glehen O; Grandclement E; Caillot JL; Francois Y; Sadeghi-Looyeh B; Gueugniaud PY; Garbit F; Benoit M; Bienvenu J; Vignal J
Anticancer Res; 1999; 19(3B):2317-21. PubMed ID: 10472351
[TBL] [Abstract][Full Text] [Related]
36. Staging and surgical treatment.
Leitao MM; Barakat RR
Cancer Treat Res; 2009; 149():35-61. PubMed ID: 19763430
[No Abstract] [Full Text] [Related]
37. [Renal cell carcinoma with malignant peritoneal mesothelioma: report of a case].
Kawakita M; Kamoto T; Okabe T; Matsumoto M
Hinyokika Kiyo; 1992 Aug; 38(8):937-40. PubMed ID: 1414743
[TBL] [Abstract][Full Text] [Related]
38. Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
Aigner C; Hoda MA; Lang G; Taghavi S; Marta G; Klepetko W
Eur J Cardiothorac Surg; 2008 Jul; 34(1):204-7. PubMed ID: 18407510
[TBL] [Abstract][Full Text] [Related]
39. Novel and existing mutations in the tyrosine kinase domain of the epidermal growth factor receptor are predictors of optimal resectability in malignant peritoneal mesothelioma.
Foster JM; Gatalica Z; Lilleberg S; Haynatzki G; Loggie BW
Ann Surg Oncol; 2009 Jan; 16(1):152-8. PubMed ID: 18998063
[TBL] [Abstract][Full Text] [Related]
40. [Malignant peritoneal mesothelioma].
Scripcariu V; Dajbog E; Lefter L; Ferariu D; Pricop A; Grigoraş M; Dragomir C
Chirurgia (Bucur); 2006; 101(6):641-6. PubMed ID: 17283842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
